by Asmaa Javed | Sep 29, 2025 | Past Awards
Priya Marathe, MD Year Awarded: 2025 Amount: $60,000 Study Length: 2 years The survival of patients with ECD has improved significantly with the increasing use of targeted therapies. Certain challenges in treating ECD still remain; these challenges include delay in...
by Asmaa Javed | Jan 23, 2024 | Past Awards
Francesco Peyronel, MD (Meyer Children’s University Hospital – IRCCS, Firenze, Italy) Year Awarded: 2024 Amount: 50,000 USD Survival of patients affected by Erdheim-Chester disease (ECD) has substantially improved over the last decades, thanks to the increased...
by Asmaa Javed | Apr 22, 2023 | Past Awards
Matthew Collin (Newcastle University, Newcastle upon Tyne, UK) Year Awarded: 2023 Amount: 200,000 USD in partnership with the Leukemia & Lymphoma Society Erdheim Chester Disease (ECD) is caused by mutations in the DNA of blood cells. Blood cells are formed in the...
by Asmaa Javed | Jan 23, 2023 | Past Awards
Gaurav Goyal (University of Alabama at Birmingham, Birmingham, AL US) Year Awarded: 2023 Amount: 200,000 USD in partnership with the Leukemia & Lymphoma Society The prognosis of ECD has improved tremendously due to the approval of targeted therapies. However,...
by Asmaa Javed | Apr 22, 2022 | Past Awards
Jithma Abeykoon Year Awarded: 2022 Amount: 20,000 USD in partnership with Uplifting Athletes Dr. Jithma Abeykoon is the Senior Associate Consultant, Assistant Professor in Hematology and Medical Oncology, and Clinician Investigator in Hematology and Medical Oncology...
by Asmaa Javed | Jan 23, 2022 | Past Awards
Drs. Egle Kvedaraite (Karolinska Institutet, Solna, Sweden) Year Awarded: 2012 Amount: 50,000 USD Dr. Egle Kvedaraite is a Postdoctoral Fellow with the Department of Pathology and Cancer Diagnostics at the Karolinska University Hospital – Unit of Molecular...
